Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients-Reference-Cited by-同舟云学术

Hepatitis B surface antigen and hepatitis B core-related antigen kinetics after adding pegylated-interferon to nucleos(t)ids analogues in hepatitis B e antigen-negative patients

Published:2020-11-27 Issue:11 Volume:12 Page:1076-1088
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:
Short-container-title:WJH

Author:

Broquetas Teresa,Garcia-Retortillo Montserrat,Micó Miquel,Canillas Lidia,Puigvehí Marc,Cañete Nuria,Coll Susana,Viu Ana,Hernandez Juan Jose,Bessa Xavier,Carrión José A

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference33 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”?

3. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

4. Natural history of chronic hepatitis B REVEALed

5. Hepatitis B Virus Core-Related Antigens as Markers for Monitoring Chronic Hepatitis B Infection

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A high functional cure rate was induced by pegylated interferon alpha-2b treatment in postpartum hepatitis B e antigen-negative women with chronic hepatitis B virus infection: an exploratory study;Frontiers in Cellular and Infection Microbiology;2024-08-08

2. Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data;Clinical Pharmacology & Therapeutics;2024-04-30

3. Combination treatment of pegylated interferon and tenofovir versus tenofovir for people with chronic hepatitis B;Cochrane Database of Systematic Reviews;2023-08-04

4. Past, present, and future of long-term treatment for hepatitis B virus;World Journal of Gastroenterology;2023-07-07

5. On-therapy HBsAg kinetics can predict HBsAg loss after nucleos(t)ide analogues interruption in HBeAg-negative patients. The cup is half full and half empty;Digestive and Liver Disease;2022-08